The automated analyzers global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Automated Analyzers Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The automated analyzers market size has grown strongly in recent years. It will grow from $4.68 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increasing awareness of preventive healthcare, the growing geriatric population, rising demand for non-invasive diagnostic tests, expansion of clinical research, and expansion of drug development activities.
The automated analyzers market size is expected to see strong growth in the next few years. It will grow to $6.64 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to expansion of veterinary diagnostics, rising focus on reducing diagnostic errors, improving patient outcomes, growth of telemedicine, and remote monitoring. Major trends in the forecast period include novel biomarkers, point-of-care diagnostics, home-based diagnostic devices, miniaturization of diagnostic devices, and development of multi-analyte testing platforms.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report
Scope Of Automated Analyzers Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Automated Analyzers Market Overview
Market Drivers –
The rising prevalence of chronic diseases is expected to propel the growth of the automated analyzers market going forward. The prevalence of chronic diseases is rising due to aging populations, unhealthy lifestyles, and increased urbanization globally. Automated analyzers are used in chronic disease management for efficient and accurate diagnostic testing, enabling early detection, monitoring, and treatment of conditions like diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based non-profit organization, approximately 7.2 million people in the UK are living with chronic kidney disease, representing over 10% of the population. Of these, 3.25 million are in the advanced stages of the disease, while an additional 3.9 million are in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Therefore, the rising prevalence of chronic diseases is driving the growth of the automated analyzers market.
Market Trends –
Major companies operating in the automated analyzers market are focusing on developing innovative solutions such as automated clinical chemistry analyzers to enhance efficiency, accuracy, and throughput in diagnostic laboratories. Automated clinical chemistry analyzers refer to advanced instruments used in laboratories to perform a wide range of chemical tests on blood and other bodily fluids with minimal human intervention, enhancing efficiency and accuracy in diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, launched the DxC 500 AU Chemistry Analyzer, which represents a cutting-edge advancement in automated clinical chemistry. Boasting over 120 high-quality assays, this analyzer is engineered to significantly enhance the capabilities of satellite and independent community hospital labs. It integrates sophisticated automation, streamlined workflows, and standardized reagents to boost testing efficiency and aid in clinical decision-making. By serving as a vital complement to central hub laboratories within healthcare systems that utilize hub-and-spoke models, the DxC 500 AU enhances overall efficiency and expands access to essential testing services.
The automated analyzers market covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Get an inside scoop of the automated analyzers market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp
Regional Insights –
North America was the largest region in the automated analyzers market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson, and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc., bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
Table of Contents
1. Executive Summary
2. Automated Analyzers Market Report Structure
3. Automated Analyzers Market Trends And Strategies
4. Automated Analyzers Market – Macro Economic Scenario
5. Automated Analyzers Market Size And Growth
…..
27. Automated Analyzers Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
